Enliven Therapeutics, Inc. [ELVN] - Enliven Therapeutics appoints new Director

Enliven Therapeutics, Inc. appointed Ms. Ball as a Director effective October 14, 2026, bringing extensive executive leadership and financial expertise in the biotechnology industry as the company prepares for its pivotal Phase 3 trial of relcobatinib.

View source filing ↗